BRPI1009200A2 - derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda - Google Patents

derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda

Info

Publication number: BRPI1009200A2
Authority: BR; Brazil
Prior art keywords: thiadiazepines; ampa; benzo; derivatives; nmda receptor
Prior art date: 2009-03-20

Application number

BRPI1009200A

Other languages

English (en)

Inventor

Cordi Alexis

Danober Laurence

Desos Patrice

Lestage Pierre

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-20

Filing date

2010-03-18

Publication date

2017-06-13

2010-03-18 Application filed by Servier Lab filed Critical Servier Lab

2017-06-13 Publication of BRPI1009200A2 publication Critical patent/BRPI1009200A2/pt

Links

UUDAMDVQRQNNHZ-UHFFFAOYSA-N (S)-AMPA Chemical compound CC=1ONC(=O)C=1CC(N)C(O)=O UUDAMDVQRQNNHZ-UHFFFAOYSA-N 0.000 title 1
KAOYLRLQZXRRBD-UHFFFAOYSA-N 1,2,3-benzothiadiazepine Chemical class S1N=NC=CC2=CC=CC=C12 KAOYLRLQZXRRBD-UHFFFAOYSA-N 0.000 title 1
102000003678 AMPA Receptors Human genes 0.000 title 1
108090000078 AMPA Receptors Proteins 0.000 title 1
102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 title 1
108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/36—Seven-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI1009200A 2009-03-20 2010-03-18 derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda BRPI1009200A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0901300A FR2943342B1 (fr)	2009-03-20	2009-03-20	Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
PCT/FR2010/000227 WO2010106249A1 (fr)	2009-03-20	2010-03-18	Derives de benzothiadiazepines en tant que modulateures des recepteurs ampa et nmda

Publications (1)

Publication Number	Publication Date
BRPI1009200A2 true BRPI1009200A2 (pt)	2017-06-13

Family

ID=40863576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1009200A BRPI1009200A2 (pt)	2009-03-20	2010-03-18	derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda

Country Status (44)

Country	Link
US (1)	US8236790B2 (pt)
EP (1)	EP2246339B1 (pt)
JP (1)	JP5437473B2 (pt)
KR (1)	KR101431504B1 (pt)
CN (1)	CN102361860B (pt)
AP (1)	AP3050A (pt)
AR (1)	AR075892A1 (pt)
AT (1)	ATE513822T1 (pt)
AU (1)	AU2010200815B2 (pt)
BR (1)	BRPI1009200A2 (pt)
CA (1)	CA2696705C (pt)
CL (1)	CL2011002287A1 (pt)
CO (1)	CO6361956A2 (pt)
CR (1)	CR20110484A (pt)
CU (1)	CU24030B1 (pt)
CY (1)	CY1111807T1 (pt)
DK (1)	DK2246339T3 (pt)
EA (1)	EA020259B1 (pt)
EC (1)	ECSP11011340A (pt)
ES (1)	ES2368691T3 (pt)
FR (1)	FR2943342B1 (pt)
GE (1)	GEP20135862B (pt)
HN (1)	HN2011002458A (pt)
HR (1)	HRP20110626T1 (pt)
IL (1)	IL215016A (pt)
JO (1)	JO2780B1 (pt)
MA (1)	MA33131B1 (pt)
MX (1)	MX2011009638A (pt)
MY (1)	MY154001A (pt)
NI (1)	NI201100169A (pt)
NZ (1)	NZ595082A (pt)
PE (1)	PE20120113A1 (pt)
PL (1)	PL2246339T3 (pt)
PT (1)	PT2246339E (pt)
RS (1)	RS51919B (pt)
SA (1)	SA110310217B1 (pt)
SG (1)	SG174274A1 (pt)
SI (1)	SI2246339T1 (pt)
TN (1)	TN2011000469A1 (pt)
TW (1)	TWI388326B (pt)
UA (1)	UA100477C2 (pt)
UY (1)	UY32475A (pt)
WO (1)	WO2010106249A1 (pt)
ZA (1)	ZA201001905B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ME02847B (me)	2009-07-27	2018-01-20	Gilead Sciences Inc	Fuzionisana heterociklična jedinjenja kao modulatori jonskih kanala
BR112012033402A2 (pt)	2010-07-02	2017-01-24	Gilead Sciences Inc	moduladores de canais de íons conforme os compostos heterocíclicos fundidos
PE20131116A1 (es)	2010-08-10	2013-10-24	Takeda Pharmaceutical	Compuestos heterociclicos potenciadores de ampa
PL3400944T3 (pl)	2010-11-04	2020-11-16	Albireo Ab	Inhibitory ibat w leczeniu chorób wątroby
ES2648820T3 (es)	2011-05-10	2018-01-08	Gilead Sciences, Inc.	Compuestos heterocíclicos condensados como moduladores de los canales de sodio
AU2015224425B2 (en) *	2011-07-01	2017-02-09	Gilead Sciences, Inc.	Fused benzoxazepinones as ion channel modulators
TWI478908B (zh) *	2011-07-01	2015-04-01	Gilead Sciences Inc	作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (pt)	2011-07-01	2018-04-28
JP6134654B2 (ja)	2012-02-08	2017-05-24	武田薬品工業株式会社	複素環化合物およびその用途
US11801226B2 (en)	2018-06-20	2023-10-31	Albireo Ab	Pharmaceutical formulation of odevixibat
DK3921028T3 (da)	2019-02-06	2023-01-23	Albireo Ab	Benzothiadiazepinforbindelser og anvendelse deraf som galdesyremodulatorer
PE20221341A1 (es)	2019-09-16	2022-09-13	Takeda Pharmaceuticals Co	Derivados de piridazin-3(2h)-ona fusionados con azol
DK4069360T3 (da)	2019-12-04	2024-02-26	Albireo Ab	Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer
CN111548325A (zh) *	2020-05-16	2020-08-18	西安都创医药科技有限公司	一种卤代苯并硫氮杂卓化合物的制备方法及其制备的产品及其应用
CN111620838A (zh) *	2020-05-16	2020-09-04	西安都创医药科技有限公司	一种氯代苯并硫氮杂卓化合物的制备方法及其制备的产品及其应用
CN111518055A (zh) *	2020-05-16	2020-08-11	西安都创医药科技有限公司	一种苯并硫氮杂卓氧化物的制备方法及其制备的产品及其应用
CN111574475B (zh) *	2020-06-03	2022-09-20	西安都创医药科技有限公司	卤代苯并硫杂卓氧化物的制备方法及其制备的产品及其应用
JP2023549226A (ja)	2020-11-12	2023-11-22	アルビレオエービー	進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット
WO2022117778A1 (en)	2020-12-04	2022-06-09	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators
CN115368363B (zh) *	2021-05-17	2024-02-20	中山大学	一种手性或消旋的嘧啶并二氮杂环庚酮类化合物及其制备方法和应用
TW202313579A (zh)	2021-06-03	2023-04-01	瑞典商艾爾比瑞歐公司	苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
CN121175293A (zh) *	2023-05-25	2025-12-19	正大天晴药业集团股份有限公司	一种苯并噻二氮卓化合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0636124A1 (fr) *	1992-04-15	1995-02-01	Aventis Pharma S.A.	Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant
EP1054877A1 (en) *	1998-02-11	2000-11-29	Du Pont Pharmaceuticals Company	Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
HUP0101280A3 (en) *	1998-02-18	2003-02-28	Neurosearch As	Positive ampa receptor modulator compounds and their use
US6156746A (en) *	1998-08-25	2000-12-05	Bristol-Myers Squibb Company	1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents
GB0209467D0 (en) *	2002-04-25	2002-06-05	Astrazeneca Ab	Chemical compounds
DE10300973A1 (de) *	2003-01-14	2004-07-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Carbonsäuren und deren Ester, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2877338B1 (fr) *	2004-11-03	2007-01-26	Servier Lab	Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) *	2004-12-10	2007-02-16	Servier Lab	Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2009
- 2009-03-20 FR FR0901300A patent/FR2943342B1/fr not_active Expired - Fee Related
2010
- 2010-03-02 JO JO201077A patent/JO2780B1/en active
- 2010-03-03 AU AU2010200815A patent/AU2010200815B2/en not_active Ceased
- 2010-03-04 UY UY0001032475A patent/UY32475A/es unknown
- 2010-03-11 TW TW099107121A patent/TWI388326B/zh not_active IP Right Cessation
- 2010-03-17 ZA ZA2010/01905A patent/ZA201001905B/en unknown
- 2010-03-17 CA CA2696705A patent/CA2696705C/fr not_active Expired - Fee Related
- 2010-03-17 SA SA110310217A patent/SA110310217B1/ar unknown
- 2010-03-18 MA MA34178A patent/MA33131B1/fr unknown
- 2010-03-18 PT PT10290141T patent/PT2246339E/pt unknown
- 2010-03-18 ES ES10290141T patent/ES2368691T3/es active Active
- 2010-03-18 DK DK10290141.0T patent/DK2246339T3/da active
- 2010-03-18 JP JP2012500288A patent/JP5437473B2/ja not_active Expired - Fee Related
- 2010-03-18 SG SG2011064367A patent/SG174274A1/en unknown
- 2010-03-18 MY MYPI2011004188A patent/MY154001A/en unknown
- 2010-03-18 KR KR1020117024772A patent/KR101431504B1/ko not_active Expired - Fee Related
- 2010-03-18 SI SI201030006T patent/SI2246339T1/sl unknown
- 2010-03-18 PE PE2011001589A patent/PE20120113A1/es not_active Application Discontinuation
- 2010-03-18 WO PCT/FR2010/000227 patent/WO2010106249A1/fr not_active Ceased
- 2010-03-18 BR BRPI1009200A patent/BRPI1009200A2/pt not_active IP Right Cessation
- 2010-03-18 MX MX2011009638A patent/MX2011009638A/es active IP Right Grant
- 2010-03-18 EP EP10290141A patent/EP2246339B1/fr active Active
- 2010-03-18 AT AT10290141T patent/ATE513822T1/de active
- 2010-03-18 UA UAA201112094A patent/UA100477C2/uk unknown
- 2010-03-18 AP AP2011005935A patent/AP3050A/xx active
- 2010-03-18 PL PL10290141T patent/PL2246339T3/pl unknown
- 2010-03-18 EA EA201101334A patent/EA020259B1/ru not_active IP Right Cessation
- 2010-03-18 RS RS20110385A patent/RS51919B/sr unknown
- 2010-03-18 NZ NZ595082A patent/NZ595082A/en not_active IP Right Cessation
- 2010-03-18 GE GEAP201012414A patent/GEP20135862B/en unknown
- 2010-03-18 CN CN201080012931.3A patent/CN102361860B/zh not_active Expired - Fee Related
- 2010-03-19 AR ARP100100881A patent/AR075892A1/es unknown
- 2010-03-19 US US12/661,598 patent/US8236790B2/en not_active Expired - Fee Related
2011
- 2011-08-31 HR HR20110626T patent/HRP20110626T1/hr unknown
- 2011-09-07 CU CU2011000169A patent/CU24030B1/es active IP Right Grant
- 2011-09-07 IL IL215016A patent/IL215016A/en not_active IP Right Cessation
- 2011-09-08 CY CY20111100869T patent/CY1111807T1/el unknown
- 2011-09-12 CR CR20110484A patent/CR20110484A/es unknown
- 2011-09-13 NI NI201100169A patent/NI201100169A/es unknown
- 2011-09-15 CL CL2011002287A patent/CL2011002287A1/es unknown
- 2011-09-19 CO CO11121546A patent/CO6361956A2/es active IP Right Grant
- 2011-09-19 EC EC2011011340A patent/ECSP11011340A/es unknown
- 2011-09-19 TN TN2011000469A patent/TN2011000469A1/fr unknown
- 2011-09-20 HN HN2011002458A patent/HN2011002458A/es unknown

Also Published As

Publication number	Publication date
HK1167404A1 (en)	2012-11-30
GEP20135862B (en)	2013-06-25
ZA201001905B (en)	2010-11-24
MA33131B1 (fr)	2012-03-01
TW201036615A (en)	2010-10-16
CU20110169A7 (es)	2012-02-15
JO2780B1 (en)	2014-03-15
MX2011009638A (es)	2011-09-28
NZ595082A (en)	2013-12-20
HN2011002458A (es)	2014-05-19
AP2011005935A0 (en)	2011-10-31
IL215016A0 (en)	2011-11-30
MY154001A (en)	2015-04-30
CA2696705A1 (fr)	2010-09-20
SI2246339T1 (sl)	2011-09-30
AU2010200815B2 (en)	2015-05-07
CY1111807T1 (el)	2015-10-07
TWI388326B (zh)	2013-03-11
US8236790B2 (en)	2012-08-07
ECSP11011340A (es)	2011-10-31
CL2011002287A1 (es)	2012-02-03
SA110310217B1 (ar)	2013-06-15
IL215016A (en)	2013-08-29
CN102361860A (zh)	2012-02-22
PT2246339E (pt)	2011-08-01
SG174274A1 (en)	2011-10-28
FR2943342B1 (fr)	2011-03-04
CA2696705C (fr)	2013-02-12
EP2246339A1 (fr)	2010-11-03
ATE513822T1 (de)	2011-07-15
DK2246339T3 (da)	2011-10-10
US20100240635A1 (en)	2010-09-23
CU24030B1 (es)	2014-10-02
PE20120113A1 (es)	2012-02-24
CN102361860B (zh)	2014-09-10
AU2010200815A1 (en)	2010-10-07
EP2246339B1 (fr)	2011-06-22
NI201100169A (es)	2012-01-11
JP5437473B2 (ja)	2014-03-12
CO6361956A2 (es)	2012-01-20
FR2943342A1 (fr)	2010-09-24
EA020259B1 (ru)	2014-09-30
KR20110128209A (ko)	2011-11-28
UA100477C2 (uk)	2012-12-25
AP3050A (en)	2014-11-30
ES2368691T3 (es)	2011-11-21
UY32475A (es)	2010-09-30
AR075892A1 (es)	2011-05-04
TN2011000469A1 (fr)	2013-03-27
WO2010106249A1 (fr)	2010-09-23
JP2012520858A (ja)	2012-09-10
RS51919B (sr)	2012-02-29
PL2246339T3 (pl)	2011-11-30
EA201101334A1 (ru)	2012-04-30
HRP20110626T1 (hr)	2011-10-31
CR20110484A (es)	2011-10-24
KR101431504B1 (ko)	2014-08-20

Legal Events

Date	Code	Title	Description
2018-01-16	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-05-08	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Publication	Publication Date	Title
BRPI1009200A2 (pt)	2017-06-13	derivados de benzo tiadiazepinas como moduladores dos receptores ampa e nmda
BRPI1012770A2 (pt)	2016-11-08	derivados de tiofeno
BR112013015260A2 (pt)	2016-09-13	derivados de enxofre como moduladores de receptor de quimiocina
BRPI0918985A2 (pt)	2015-12-01	derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina
BRPI1013246A2 (pt)	2016-04-05	derivados de benzofuralina
BR112012002828A2 (pt)	2015-10-13	derivados de 5-fluorpirimidinona
BRPI0810462A2 (pt)	2014-10-14	Derivados de quinolina-carboxamida como antagonistas de p2y12
BRPI0809930A2 (pt)	2014-10-07	Derivados de carboxamida imidazolidina como moduladores de p2x7
BR112012003870A2 (pt)	2015-09-08	derivados de sulfeto substituídos com 3-triazolilfenila como acaricidas e inseticidas
BRPI1008749A2 (pt)	2015-08-25	Derivados de benzodiazepina
BRPI0913117A2 (pt)	2016-01-05	imidazopiridina e análogos relacionados como moduladores de sirtuína
BR112012015868A2 (pt)	2017-06-20	derivados de imidazolidinadiona
BRPI1006128A2 (pt)	2016-11-01	derivados de sulfonamida
PT2496567T (pt)	2017-11-15	Novos moduladores de quinase benzopiran
CU24152B1 (es)	2016-02-29	1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
BRPI1011477A2 (pt)	2016-03-22	quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina
BRPI1013844A2 (pt)	2016-04-12	derivados de piridina-isoxazol
BR112012008159A2 (pt)	2016-03-01	moduladores de receptor canabinoide
BR112012008108A2 (pt)	2015-09-22	derivados de xantina substituídos
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
CU23870B1 (es)	2013-03-27	Derivados de ciclopropilamida como moduladores h3
BRPI0822058A2 (pt)	2015-06-23	Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7
BR112012010519A2 (pt)	2017-12-05	derivados de sulfonamida heterocíclicos
BR112013023914A2 (pt)	2016-12-13	derivados de benzo [b] [1,4] oxazina como moduladores de receptor sensor de cálcio
DK2297100T3 (da)	2012-12-17	Tetrahydrocyclopenta[b]indol-androgenreceptor-modulatorer